Merck is expanding domestic manufacturing with a $895 million investment in its Kansas factory, one of several major projects ...

U.S. drug maker Merck is building a $1 billion facility in Wilmington, Delaware, aimed at increasing domestic production of ...

A new manufacturing plant in De Soto will be a Center of Excellence for the global company, along with expanded R&D ...

The 470,000-square-foot facility will support the launch and commercial production of next-generation biologics and therapies ...

Merck & Co., Inc. (NYSE ... He also said that the company’s decision to invest in domestic manufacturing was driven by “what the current administration is doing and what President Trump ...

Merck Animal Health will invest $895 million to expand vaccine manufacturing and R&D in Kansas, while Lilly is committing ...

We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands ...

Merck Animal Health Announces $895 Million ... and Gilead have recently announced additional investments to boost domestic production amid U.S. President Donald Trump's tariff policies.

US court shuts down AstraZeneca's challenge to Medicare drug price plan A federal appeals court on Thursday shut down AstraZeneca’s challenge to the U.S. government’s program that gives the ...